Utility of Pre-4-Hour Acetaminophen Levels in Acute Overdose

2017-03-05T14:18:52+00:00

Utility of Pre-4-Hour Acetaminophen LevelsCase Presentation: A 37 y/o woman presents to the ED with altered mental status. The vital signs are within normal limits. The history is provided by a friend who states that the patient was normal 2 hours ago when they were together. When she returned home, she found the patient in this state next to an empty bottle of acetaminophen (APAP) and 5 empty beer cans. A recent loss in the family has led to some depression in the last few weeks. A battery of labs are sent off including a ‘tox panel’ consisting of serum EtOH, salicylate, and APAP levels. The presumed time of ingestion is 2 hours prior to presentation.

Question 1:

Can APAP concentrations < 100 mcg/mL obtained between 1-4 hours after acute ingestion accurately predict a nontoxic 4-hour concentration?

The Rumack-Matthew nomogram starts at 4 hours after an acute ingestion. We commonly order a host of labs as soon as the patient is examined. So, what do we do with an APAP concentration drawn before 4 hours since the ingestion?

Three studies directly address this topic.

Study 1 

One group studied 83 patients that met the following inclusion criteria: acute APAP ingestion and serum APAP level < 100 mcg/mL between 1 and 4 hours post-ingestion.1 They found two cases that had a subtoxic levels prior to 4 hours post-ingestion (54 mcg/mL at 90 minutes and 38 mcg/mL at 84 minutes) which were found to be above the line after 4 hours (240 mcg/mL at 300 minutes and a 93 mcg/mL at 227 minutes, respectively). This accounted for a negative predictive value (NPV) of 98.8% and a potential false-negative rate of 6.5%. A miss rate of 6.5% is not acceptable. Interestingly, the NPV was 100% at 2-4 hours post-ingestion.

Study 2 (Douglas DR, et al. Vet Human Toxicol 1994;36:350. [abstract])

Presented only in abstract form, this study reported on a retrospective analysis. The authors analyzed APAP concentrations from patients presenting within 4 hours of ingestion. They reported a NPV of:

  • 76% for APAP concentrations drawn within 1 hour
  • 88% for concentrations drawn between 1 and 2 hours
  • 98% for concentrations drawn between 2 and 3 hours
  • 99% for concentrations drawn between 3 and 4 hours after ingestion

Overall, using the data from their table, APAP concentrations less than 100 mcg/mL drawn between 1 and 4 hours after ingestion had a NPV of 94.6%. Similar to Study 1 above, there were still patients with potentially toxic levels after 4 hours that would have been missed and possibly needed antidotal therapy.

Study 3

The authors examined serum APAP concentrations obtained less than 4 hours post-ingestion, and again 4 or more hours post-ingestion.4 They specified a cutpoint of 100 mcg/mL (662 micromol/L) obtained between 2 and 4 hours and a subsequent 4 to 20 hour APAP concentration above the nomogram treatment line of 150 mcg/mL (993 micromol/L). Almost 2,500 patients were evaluated. Concentrations drawn between 2-4 hours post-ingestion demonstrated a sensitivity of 0.96 [95% CI; 0.94, 0.97] and a negative likelihood ratio of 0.070 [0.048, 0.10]. Coingested opioids reduced this sensitivity to 0.91 [0.83, 0.95], and antimuscarinics to 0.86 [0.72, 0.94]. Only very low to undetectable APAP concentrations prior to 4 hours reliably excluded a subsequent concentration over the treatment line. They concluded that applying an APAP concentration cutpoint of 100 mcg/mL (662 micromol/L) at 2-4 hours after an acute ingestion as a threshold for repeat testing and/or treatment would occasionally miss potentially toxic exposures. Further, their data validated the practice of not retesting when the first post-ingestion APAP concentration is below the lower limit of detection.

A letter-to-the editor was published in response to this study. In it, the authors describe a case in which a 16 year old ingested a large amount of acetaminophen with an undetectable level 75 minutes post-ingestion (time of ingestion reportedly corroborated by parents). However, this new case potentially has a few issues that may limit its applicability. First, it seems unlikely that a 75-minute post-ingestion level was undetectable after a massive overdose. The kinetics of acetaminophen after overdose are well-studied since the 1970’s. At least some is absorbed very quickly, which would produce a measurable serum concentration. Second, the authors describe the presentation as “persistent nausea and vomiting.” Why is the patient vomiting with an undetectable level if the timing is accurate? Third, cases published in letters-to-the-editor format typically do not undergo the same level of peer-review (if any) to which full case reports are generally subjected. Importantly, the authors raise a fair point: The Yamera data, by itself, does not meet the statistical rigor to definitively state that an undetectable level does not require repeating. Looking at all of the available data, though, tells a different story. There has been loads of data looking at acetaminophen levels dating back to the 1960s and 1970s. Kinetically speaking, it is highly improbable (I won’t say impossible) for a patient to have an undetectable level more than an hour after ingestion. There has never been a case reported (even within other studies) of a patient with a negative level after 1 hour who goes on to develop a toxic level at 4 hours (or later). Given all of the data and experience to date PLUS Froberg and Yamera PLUS no cases ever published going against the practice, the statistical analysis would include many more patients and be at an acceptable level for close to zero risk, improving the sensitivity, negative predictive value, and narrowing the confidence interval.

That all being said: Caution is always advised when determining times of ingestion and if there is any doubt, a repeat level should always be obtained.

Rumack-Matthew nomogram

Rumack-Matthew nomogram

Question 2:

When we order an APAP level prior to 4 hours post-ingestion, how often are we ordering a follow-up level at 4 hours?

The answer is not often.2 Of 520 acute APAP exposure cases presenting < 4 hours post-ingestion, 323 had a pre-4-hour APAP concentration measured. Only 59% had an APAP level drawn again at 4 hours. The good news is that overall, 87% of patients who had a pre-4-hour APAP level had a second level drawn before 8 hours (the end of the optimal time window in which acetylcysteine should be started).

The downside of drawing levels too early is that patients with a known pre-4-hour APAP concentration were more likely to be treated with acetylcysteine (29% vs. 17%) and less likely to be treated based on the Rumack-Matthew nomogram (72% vs. 97%). The authors concluded that pre-4-hour APAP concentrations cannot be used to determine the need for acetylcysteine therapy and are associated with an increased likelihood of not obtaining optimally timed acetaminophen concentrations and acetylcysteine management not based on the proper application of the Rumack-Matthew nomogram.

As a general point of clarification on timing of APAP levels, the 4-hour level is defined as 4 hours from ingestion and not 4 hours from the first level. Levels drawn after 4 hours are ok as long as it is <8 hours following ingestion, and it is plotted properly on the nomogram.

Where Do We Stand in 2016?

There wasn’t a lot of data on this topic, that is until the latest study in 2016. Dr. Rumack’s group has provided a more definitive answer, and it confirms the previous conclusions drawn by this ALiEM post. Their study had 8 times more patients than the previously studied cohort.

In an editorial accompanying the Froberg paper, toxicologist Dr. Sean Rhyee discusses a few limitations of the findings.3 First, the broad inclusion criteria do not account for coingestants that may affect GI motility (e.g., diphenhydramine and opioids). Second, the inclusion criteria do not account for use of GI decontamination such as activated charcoal which can also affect absorption. It is not known how often activated charcoal is administered in today’s practice.

Take Home Points

  1. The Rumack-Matthew nomogram is to be utilized starting at 4 hours after an acute APAP ingestion.
  2. Pre-4 hour APAP levels, if not repeated, can lead to unnecessary treatment, admissions, and adverse effects.
  3. If an APAP level is drawn before 1 hour, a second APAP level must be drawn again at the 4-hour mark.
  4. If an APAP level is drawn between 1-4 hours, and the level is:
    Undetectable –> you can stop additional APAP testing
    Detectable –> you should redraw a second APAP level at the 4-hour mark
  5. The current data supports waiting until 4 hours after ingestion to draw a level, but optimally less than 7 hours (to allow an hour to start acetylcysteine if needed).

APAP level graphic

Note on timing of APAP levels: The 4-hour level is defined as 4 hours from ingestion and not 4 hours from the first level. Levels drawn after 4 hours are ok long as it is less than 8 hours following ingestion and it is plotted properly on the nomogram.

Case Conclusion

The 2-hour APAP level was 80 mcg/mL and antidotal therapy was initiated. A repeat level at 5 hours post-ingestion was only 34 mcg/mL, well below the treatment line on the Rumack-Matthew nomogram. The patient unfortunately suffered an anaphylactoid reaction to the acetylcysteine infusion that resolved with diphenhydramine. Once the repeat level was resulted, antidotal therapy was discontinued. This is an example of a patient treated unnecessarily based on a pre-4-hour APAP concentration.

Much thanks to Matt Zuckerman, MD and Lewis Nelson, MD for reviewing this post and providing expert peer-review.
Original: Aug 5, 2015; Updated: Oct 28, 2016; Updated Feb 7, 2017
1.
Froberg B, King K, Kurera T, et al. Negative predictive value of acetaminophen concentrations within four hours of ingestion. Acad Emerg Med. 2013;20(10):1072-1075. [PubMed]
2.
Seifert S, Kirschner R, Martin T, Schrader R, Karowski K, Anaradian P. Acetaminophen concentrations prior to 4 hours of ingestion: impact on diagnostic decision-making and treatment. Clin Toxicol (Phila). 2015;53(7):618-623. [PubMed]
3.
Rhyee S. Early serum acetaminophen levels: how soon is too soon? Acad Emerg Med. 2013;20(10):1070-1071. [PubMed]
4.
Yarema M, Green J, Sivilotti M, et al. Can a serum acetaminophen concentration obtained less than 4 hours post-ingestion determine which patients do not require treatment with acetylcysteine?<sup/> Clin Toxicol (Phila). October 2016:1-7. [PubMed]

Bryan D. Hayes, PharmD, FAACT, FASHP

Bryan D. Hayes, PharmD, FAACT, FASHP

Chief Science Officer, ALiEM
Creator and Lead Editor, Capsules series, ALiEMU
Attending Pharmacist, EM and Toxicology, MGH
Assistant Professor of EM, Harvard Medical School
  • Nadim Lalani

    a pre 4h level of 0.0 rules out an ingestion no? thanks

    • Bryan D. Hayes

      Dear Nadim,

      Thank you for your comment. This was addressed in take home point #3. If the APAP level is drawn prior to 1 hour post-ingestion, even an undetectable level should be repeated. Anecdotal cases have occurred where the 4-hour level is above the nomogram treatment line. This could be do to an incorrect history, product formulation, coingestants, etc. An undetectable level any time after 1 hour should be enough to rule out an ingestion.

      • Nadim Lalani

        ok thanks

  • Evan Schwarz

    I’d also add that in addition to exposing the patient to a medication that they didn’t need, the patient is also being charged for 2 acetaminophen concentrations when only 1 was useful clinically and for a medication (NAC) that they never required. At least at some hospitals, the test and medication can be somewhat expensive.

    • Bryan D. Hayes

      Evan, this is a great point. Thanks for bringing it up. Additionally, the ‘cost’ that we associate with a test or treatment may be very different (ie, lower) than what the patient is charged.

  • Mike Jasumback

    What about falling levels? i.e. 39 at 1hr and 12 at 2-3 hrs?

    • Bryan D. Hayes

      Great question Mike. Most likely, the levels dropping as you describe would rule out the potential for toxicity (especially with a starting level so low). However, with levels any higher, we have seen a few cases of delayed peaks and patients that cross from the non-toxic side of the nomogram to the toxic side in an unpredictable manner.

      There is a unique phenomenon called line-crossing that has been described a few times in the literature. One of them is a case I had back as a fellow (http://www.ncbi.nlm.nih.gov/pubmed/18986731), although our patient was an acetaminophen-diphenhydramine ingestion. The Maryland Poison Center has published on these “line-crossers” (http://www.ncbi.nlm.nih.gov/pubmed/21719230) as has the Nebraska at the 2014 North American Congress of Clinical Toxicology meeting (Clin Toxicol 2014;52(7):682-818. Abstract #29). Several of these patients did have bad outcomes including liver failure and death. The bimodal peak is also described several times in the literature (refer to references in my case report cited above).

      I don’t think we need to change our use of the nomogram except to potentially repeat the level if there is any question of extended release acetaminophen or acetaminophen combination products with drugs that slow GI motility (eg, diphenhydramine or opioids). Many don’t believe this line crossing phenomenon even matters, but it might. There are newer tools being developed such as the PSI parameter to help predict who really needs to be treated (http://www.ncbi.nlm.nih.gov/pubmed/21819286, http://www.ncbi.nlm.nih.gov/pubmed/24765894, and http://www.ncbi.nlm.nih.gov/pubmed/24844577)

  • Michael Szava-Kovats

    Would you extrapolate the existing treatment line to times before 4 hours and treat above this without a 4 hour level?

    • Bryan D. Hayes

      You could reasonably make the argument that if the level is above a certain threshold (eg, 500 mcg/mL) before 4 hours, then it would be unlikely to be below the line at 4 hours. However, this hasn’t been studied and there isn’t a linear way to predict what the level will be at 4 hours based solely on a pre-4-hour level.